
Professor Dimitri P. Mikhailidis has received the first ILEP Honorary Membership Award
We are so happy to announce that Professor Dimitri P. Mikhailidis from the UCL has received the first ILEP Honorary Membership Award. Thank you to
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
We are so happy to announce that Professor Dimitri P. Mikhailidis from the UCL has received the first ILEP Honorary Membership Award. Thank you to
In our next meta-analysis (the largest in the world) we showed a significant inverse association between daily step count and all-cause mortality and CV mortality
Within the group of the recognized Polish experts, based on the data from the PL-ACS Registry, for the first time in the world we confirmed
Within LBPMC Group we also evaluated the relationship between electronic nicotine delivery systems (ENDS) use and the risk of stroke when compared to non-smokers. The results
Please see the most recent ILEP expert opinion paper, just published in the European Heart Journal, on the role of low carbohydrate diet/ketogenic diet on
Statins are a widely available, cheap, safe, and extremely effective means to reduce the cardiovascular disease (CVD) risk, and it is therefore a tragedy that these
Abstract Statin intolerance is a clinical syndrome whereby adverse effects (AEs) associated with statin therapy [most commonly statin-associated muscle symptoms (SAMS)] result in the discontinuation
Abstract The risk of atherosclerotic cardiovascular disease (ASCVD) is strongly related to lifetime exposure to low-density lipoprotein (LDL)-cholesterol in longitudinal studies. Lipid-lowering therapy (using statins, ezetimibe and PCSK9 inhibitors) substantially
ILEP strongly believes in international cooperation, which is why the presence of representatives of all nationalities in our ranks is so important. If you are interested in join the ILEP, please click below to see the requirements.
During the last meeting our Experts discussed the efficacy of nutraceuticals in the therapy of lipid disorders.
ILEP Webinars Recommendations 2021
05-10.2021
ILEP Webinars on Nutraceuticals
09-10.2020
In 2020 we have been able to publish 10 papers, in which many of the ILEP members were included:
Banach M, Reiner Ž, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, Bytyçi I, Ceska R, Cicero AFG, Dudek D, Dyrbuś K, Fedacko J, Fras Z, Gaita D, Gavish D, Gierlotka M, Gil R, Gouni-Berthold I, Jankowski P, Járai Z, Jóźwiak J, Katsiki N, Latkovskis G, Magda SL, Margetic E, Margoczy R, Mitchenko O, Durak-Nalbantic A, Ostadal P, Paragh G, Petrulioniene Z, Paneni F, Pećin I, Pella D, Postadzhiyan A, Stoian AP, Trbusic M, Udroiu CA, Viigimaa M, Vinereanu D, Vlachopoulos C, Vrablik M, Vulic D, Penson PE; International Lipid Expert Panel (ILEP)
Surma S, Sahebkar A, Banach M; endorsed by the International Lipid Expert Panel (ILEP)
Bielecka-Dabrowa A, Banach M, Wittczak A, Cicero AFG, Kallel A, Kubilius R, Mikhailidis DP, Sahebkar A, Pantea Stoian A, Vinereanu D, Penson PE, von Haehling S.
ILEP Webinars Recommendations 2021
The 2nd Edition of ILEP Webinars starts.
ILEP hosts the 1st Edition of ILEP Webinars.
Professor Maciej Banach founds the International Lipid Expert Panel.
In case of any questions, please contact the ILEP Secretary – Patrycja Lewandowicz: